139042-59-4

Basic information

• Product Name: 1-(6-BROMO-PYRIDIN-3-YL)-ETHANONE
• Synonyms: 3-ACETYL-6-BROMOPYRIDINE;1-(6-BROMO-PYRIDIN-3-YL)-ETHANONE;2-BROMO-5-ACETYLPYRIDINE;5-acetyl-2-bromopyridine;1-(6-Bromopyrid-3-yl)ethan-1-one;5-Acetyl-2-bromopyridine 97%;1-(6-BROMOPYRID-3-YL)ETHANONE;1-(6-Bromopyridin-3-yl)ethan-1-one
• CAS NO: 139042-59-4
• Molecular Formula: C₇H₆BrNO
• Molecular Weight: 200.03
• EINECS: 625-249-8
• Product Categories: Pyridine;Heterocycle-Pyridine series
• Mol File: 139042-59-4.mol
• Article Data: 9

Chemical Properties

• Melting Point: 124-128 °C(lit.)
• Boiling Point: 291.3 °C at 760 mmHg
• Flash Point: 130 °C
• Appearance: light yellow to dark yellow liquid
• Density: 1.534 g/cm³
• Vapor Pressure: 0.00196mmHg at 25°C
• Refractive Index: 1.558
• Storage Temp.: Inert atmosphere,Room Temperature
• Solubility: soluble in Methanol
• PKA: -1.01±0.10(Predicted)
• CAS DataBase Reference: 1-(6-BROMO-PYRIDIN-3-YL)-ETHANONE(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(6-BROMO-PYRIDIN-3-YL)-ETHANONE(139042-59-4)
• EPA Substance Registry System: 1-(6-BROMO-PYRIDIN-3-YL)-ETHANONE(139042-59-4)

Safety Data

• Hazard Codes: Xi
• Statements: 36/37/38
• Safety Statements: 26-36
• WGK Germany: 3
• Hazardous Substances Data: 139042-59-4(Hazardous Substances Data)

Usage

General Description

1-(6-Bromo-pyridin-3-yl)-ethanone is a chemical compound with the molecular formula C7H6BrNO. It is an organic compound that contains a pyridine ring substituted with a bromine atom and an ethanone group. It is commonly used as an intermediate in the synthesis of pharmaceuticals and agrochemicals. This chemical is an important building block for the development of various biologically active compounds and materials. Its properties and reactivity make it a useful tool for researchers and chemists in drug discovery and organic synthesis.

InChI:InChI=1/C7H6BrNO/c1-5(10)6-2-3-9-7(8)4-6/h2-4H,1H3

Upstream product

• 624-28-2 2,5-dibromopyridine 
• 127-19-5 N,N-dimethyl acetamide 
• 13534-97-9 6-bromopyridine-3-amine 
• 431-03-8 dimethylglyoxal 

Downstream Products

• 136592-20-6 2-bromo-1-(6-bromopyridin-3-yl)ethanone 
• 958456-33-2 (E)-1-(6-bromopyridin-3-yl)-3-(4-(dimethylamino)phenyl)prop-2-en-1-one 
• 1227158-50-0 1-(6-(phenylamino)pyridin-3-yl)ethanone 
• 1211521-60-6 2-bromo-5-(1,1-difluoroethyl)pyridine 
• 1569902-04-0 6-ethyl-5-[3-(6-phenyl-pyridin-3-yl)-but-1-ynyl]-pyrimidine-2,4-diamine 
• 1569902-02-8 5-(1-methyl-prop-2-ynyl)-2-p-tolyl-pyridine 
• 1569902-05-1 6-ethyl-5-[3-(6-p-tolyl-pyridin-3-yl)-but-1-ynyl]-pyrimidine-2,4-diamine 
• 1216790-93-0 1-(6-(p-tolyl)pyridin-3-yl)ethanone 
• 265107-85-5 5-acetyl-2-(pyrazole-1-yl)pyridine 
• 1610543-96-8 1-(6-((1-(3,4-dimethoxybenzyl)piperidin-2-yl)methoxy)pyridin-3-yl)ethanone 
• 1610553-24-6 C₂₁H₂₃N₃O₂ 
• 1610552-68-5 C₂₀H₂₂F₂N₂O₂ 

Relevant articles and documents

Photoinduced Acetylation of Anilines under Aqueous and Catalyst-Free Conditions

A green and efficient visible-light induced functionalization of anilines under mild conditions has been reported. Utilizing nontoxic, cost-effective, and water-soluble diacetyl as photosensitizer and acetylating reagent, and water as the solvent, a variety of anilines were converted into the corresponding aryl ketones, iodides, and bromides. With advantages of environmentally friendly conditions, simple operation, broad substrate scope, and functional group tolerance, this reaction represents a valuable method in organic synthesis.

RADIONUCLIDE-LABELED COMPOUND AND IMAGING AGENT CONTAINING THE SAME

PROBLEM TO BE SOLVED: To provide: a radionuclide-labeled compound having both tau protein affinity and amyloid protein affinity; an imaging agent that contains the radionuclide-labeled compound and that is used for imaging tau proteins and/or amyloid proteins; and a radioactive medicine that contains the radionuclide-labeled compound and that is used for diagnostic imaging of diseases caused by the aggregation of tau proteins and/or amyloid proteins. SOLUTION: The present invention provides radionuclide-labeled compounds represented by general formula (1) or salts thereof. (In the formula, X represents a radioactive iodine atom,18F or 11CH3; pyridine and oxazole are bound by a carbon atom; and pyridine is bound to imidazopyridine by a carbon atom.) SELECTED DRAWING: None COPYRIGHT: (C)2019,JPO&INPIT

Design and synthesis of new anticancer pyrimidines with multiple-kinase inhibitory effect

A new series of N-substituted-2-aminopyrimidines based on the '4-(pyridin-3-yl)pyrimidin-2-amine' scaffold of Imatinib has been designed and synthesized. A selected group from the target compounds was tested over a panel of 60 cancer cell lines at a single dose concentration of 10 μM, and the two most active compounds, 25b and 30, were further tested in a five-dose testing mode to determine their IC50 values over the 60 cell lines. Compound 30 has showed good potencies and high efficacies, and was accordingly tested at a single dose concentration of 10 μM over a panel of 54 kinases. At this concentration, the compound has showed multiple inhibitions over a number of oncogenic kinases, including ABL1, AKT1, LCK, C-SRC, PIM1, FLT3, FYN, and KDR. A molecular modeling study was made by docking of the most active compound 30 and its inactive analog 29 into the kinase domain of ABL1 to investigate their possible binding interactions.